(1) Plans, evaluates and coordinates extramural clinical research programs testing combined modality approaches and the testing of investigational new agents; (2) directs the evaluation of the effectiveness of specific types and methods of cancer therapy and analyzes and assesses the applicability of new methods and agents in the clinical treatment of cancer; (3) coordinates the exchange of scientific information with foreign organizations and institutions on all aspects of cancer treatment; (4) coordinates the activities of the branches within the Program to assure orderly evaluation and assessment of drug compounds and of other specific modalities in treating human malignancies; and (5) assesses the activities of the Program as a whole and advises the Division Director as to new areas of promising potential in the clinical treatment of cancer in humans.
|
